Health Care Fraud in a Time of Increased Judicial Scrutiny
Scholar warns that the fall of Chevron deference could destabilize health care fraud enforcement.
The Governance Gap in Clinical AI
Federal regulators misunderstand the value of transparency rules for clinical AI.
The Department of Labor Should Put Down the Pen
Congress has declared its intent on pharmacy benefit manager reform, and the Labor Department should heed it.
AI Governance Starts at Home
HHS’s new artificial intelligence strategy tests management-based regulation.
Who Is Really in Charge of Drug Scheduling?
Scholar argues that HHS and the DEA should balance each other’s federal drug scheduling authority.
Adding Autism Claims to the VICP Would Likely Destroy It
The costs of covering serious autism cases under the National Vaccine Injury Compensation Program (VICP) could undermine childhood vaccine production.
The Growing Pains of the No Surprises Act
Scholars reflect on the continuing impact of the No Surprises Act.
Expert Officers Under Political Supervision
The Supreme Court validates political control over public health decisions.
The Price of Preserving Preventive Services Coverage
The Supreme Court preserves preventive services coverage but emboldens the HHS Secretary.
How We Subsidize Care for Low-Income People
A Supreme Court decision reveals flaws in how we pay safety-net hospitals—and why reform is overdue.
Making Drugs Affordable Through Personal Importation
Personal importation is the fastest route to “most-favored-nation” drug pricing.
Tackling America’s High Drug Prices
Scholars discuss policy approaches to lowering the price of prescription drugs.